moa of glp 1 GLP-1 and Anesthesia: Considerations and Cautions for CRNAs GLP-1 Receptor Agonists as Treatments

doi: 10.1016/j.neuropharm.2016.03.021

The GLP-1 and GIP components enhance insulin secretion and sensitivity, while the glucagon component, somewhat paradoxically, does not worsen blood sugar control because its glucose-raising effects are offset by the dominant insulin-enhancing effects of the other two pathways

(AB Sciex, USA) were used for data acquisition control and initial data preprocessing for quality control

10.1016/j.tips.2024.04.012 130 OwenM

There are many types of seizures

Discontinuation should be restricted to the small subset of patients with high-risk procedures, recent high-dose drug exposure, and either positive ultrasound findings or significant symptoms